Respiratorius AB (publ) (HF0.F)

0.0030 0.0000 (0.00%) As of 08:25AM CEST. Market open.

Respiratorius AB (publ)

Medicon Village
Scheelevagen 2
Lund 223 81
Sweden
46 7 09 22 41 40
https://www.respiratorius.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Description

Respiratorius AB (publ), a research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma. The company's products under development include VAL001, which has completed Phase III clinical trials for the treatment of diffuse large B-cell lymphoma; and VAL001, a product candidate that is in preclinical phase for the treatment of relapsing diffuse large B-cell lymphoma. Respiratorius AB (publ) was incorporated in 1998 and is based in Lund, Sweden.

Corporate governance

Respiratorius AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.